Skip to main content
Clinical Trials/NCT00680238
NCT00680238
Completed
Not Applicable

Pregnancy and Implantation Rates When Embryos Are Selected Based on a Single Day 3 Score (Day 3)vs Graduated Embryo Score(GES) Plus Soluble Human Leukocyte Antigen-G Expression.

University of Stellenbosch0 sites214 target enrollmentJune 2004

Overview

Phase
Not Applicable
Intervention
Human derived FSH
Conditions
Infertility
Sponsor
University of Stellenbosch
Enrollment
214
Primary Endpoint
Pregnancy and implantation rates
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.

Detailed Description

Comparing pregnancy rates and implantation rates when embryos are selected using the most common criteria for embryo selection on day 3 - the morphology-(number of blastomere, their shape and size and the percentage of fragmentation)vs a graduated embryo score accumulated over 72 hours and the expression of sHLA-G at 44-46 hours post fertilization.

Registry
clinicaltrials.gov
Start Date
June 2004
End Date
June 2007
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Self paying ART patients

Exclusion Criteria

  • Abnormal uterus
  • Specific Immunologic factors

Arms & Interventions

A

Embryo selection for transfer based on a Day 3 score only.

Intervention: Human derived FSH

B

Embryos for transfer by first selecting any embryos that had a positive sHLA-G expression of OD = 190 ±6 and correlating such with the highest GES score available.

Intervention: Human derived FSH

Outcomes

Primary Outcomes

Pregnancy and implantation rates

Time Frame: 12 weeks

Secondary Outcomes

  • Miscarriage rates(9-11 day until βhCG)

Similar Trials